Trial Profile
A prospective trial to evaluate the safety, efficacy and drug-drug interactions between Elbasvir/grazoprevir and other immunosuppressant agents - cyclosporine, tacrolimus, mycophenolate mofetil and prednisone in healthy adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2018
Price :
$35
*
At a glance
- Drugs Elbasvir/grazoprevir (Primary) ; Mycophenolate mofetil; Prednisone; Tacrolimus
- Indications Hepatitis C
- Focus Pharmacokinetics
- 12 Jan 2018 Results published in the Journal of Clinical Pharmacology
- 11 Mar 2016 New trial record